Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

China flag China · Delayed Price · Currency is CNY
14.42
-0.19 (-1.30%)
May 20, 2026, 11:29 AM CST
Market Cap8.06B -33.6%
Revenue (ttm)10.20B -7.3%
Net Income111.65M
EPS0.21
Shares Out551.42M
PE Ratio70.85
Forward PE29.22
Dividendn/a
Ex-Dividend Daten/a
Volume5,333,700
Average Volume5,860,301
Open14.52
Previous Close14.61
Day's Range14.19 - 14.75
52-Week Range14.24 - 25.51
Beta0.32
RSI26.21
Earnings DateApr 30, 2026

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; an... [Read more]

Sector Healthcare
Founded 1979
Employees 10,864
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600129
Full Company Profile

Financial Performance

In 2025, SHA:600129's revenue was 10.50 billion, a decrease of -15.23% compared to the previous year's 12.39 billion. Earnings were 120.57 million, an increase of 352.37%.

Financial Statements